Citigroup »

Blueprint Medicines shares owned by Citigroup

Quarter-by-quarter ownership of Blueprint Medicines (BPMC) shares owned by Citigroup from 13F filings

Historical chart of Citigroup investment in Blueprint Medicines

Tip: Access up to 7 years of quarterly data

All positions including Blueprint Medicines held by Citigroup consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Blueprint Medicines by Citigroup

Quarter filed Position value Share count Share price at filing
2023-12-31 $17M 179k 92.20
2023-09-30 $6.1M 122k 50.22
2023-03-31 $8.9M 198k 45.00
2022-12-31 $6.0M 137k 43.81
2022-09-30 $12M 177k 66.67
2021-12-31 $6.8M 63k 107.01
2021-03-31 $4.3M 44k 96.88
2020-12-31 $1.6M 14k 111.81
2020-09-30 $615k 6.6k 92.92
2020-06-30 $2.8M 36k 78.10
2020-03-31 $2.4M 41k 58.49
2019-12-31 $1.8M 22k 80.19
2019-09-30 $2.0M 27k 73.50
2019-06-30 $6.9M 73k 94.34
2019-03-31 $2.1M 27k 80.06
2018-12-31 $7.6M 142k 53.91
2018-09-30 $14M 182k 78.06
2018-06-30 $12M 193k 63.49
2018-03-31 $57k 626 91.05
2017-12-31 $27k 363 74.38
2017-09-30 $2.0M 29k 69.67
2017-06-30 $1.8M 36k 50.66
2017-03-31 $536k 13k 39.98
2016-12-31 $1.8M 66k 28.05
2016-09-30 $190k 6.4k 29.70
2016-06-30 $128k 6.3k 20.29
2015-12-31 $2.2M 85k 26.34
2015-09-30 $1.6M 77k 21.34
2015-06-30 $6.3k 145 43.48